| Accession |
PRJCA018805 |
| Title |
Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer |
| Relevance |
Medical |
| Data types |
HER2 IHC and FISH
|
| Organisms |
Homo sapiens
|
| Description |
The purpose of this study is to evaluate the clinical efficacy and safety of HLX22 in the HER2+ Locally Adanved or Metastatic Gastric Cancer as the first-line therapy. |
| Sample scope |
Multiisolate |
| Release date |
2023-08-03 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
Li
Jin (lijin@csco.org.cn)
|
| Organization |
Shanghai East Hospital |
| Submission date |
2023-08-03 |
